SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Howell Louise) "

Search: WFRF:(Howell Louise)

  • Result 1-11 of 11
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Amrutkar, Manoj, et al. (author)
  • Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model
  • 2015
  • In: Diabetes. - : American Diabetes Association. - 0012-1797 .- 1939-327X. ; 64:8, s. 2791-2804
  • Journal article (peer-reviewed)abstract
    • Understanding the molecular networks controlling ectopic lipid deposition, glucose tolerance, and insulin sensitivity is essential to identifying new pharmacological approaches to treat type 2 diabetes. We recently identified serine/threonine protein kinase 25 (STK25) as a negative regulator of glucose and insulin homeostasis based on observations in myoblasts with acute depletion of STK25 and in STK25-overexpressing transgenic mice. Here, we challenged Stk25 knockout mice and wild-type littermates with a high-fat diet and showed that STK25 deficiency suppressed development of hyperglycemia and hyperinsulinemia, improved systemic glucose tolerance, reduced hepatic gluconeogenesis, and increased insulin sensitivity. Stk25(-/-) mice were protected from diet-induced liver steatosis accompanied by decreased protein levels of acetyl-CoA carboxylase, a key regulator of both lipid oxidation and synthesis. Lipid accumulation in Stk25(-/-) skeletal muscle was reduced, and expression of enzymes controlling the muscle oxidative capacity (Cpt1, Acox1, Cs, Cycs, Ucp3) and glucose metabolism (Glut1, Glut4, Hk2) was increased. These data are consistent with our previous study of STK25 knockdown in myoblasts and reciprocal to the metabolic phenotype of Stk25 transgenic mice, reinforcing the validity of the results. The findings suggest that STK25 deficiency protects against the metabolic consequences of chronic exposure to dietary lipids and highlight the potential of STK25 antagonists for the treatment of type 2 diabetes.
  •  
2.
  • Escala-Garcia, Maria, et al. (author)
  • A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
  • 2020
  • In: Nature Communications. - : NATURE PUBLISHING GROUP. - 2041-1723. ; 11:1
  • Journal article (peer-reviewed)abstract
    • Identifying the underlying genetic drivers of the heritability of breast cancer prognosis remains elusive. We adapt a network-based approach to handle underpowered complex datasets to provide new insights into the potential function of germline variants in breast cancer prognosis. This network-based analysis studies similar to 7.3 million variants in 84,457 breast cancer patients in relation to breast cancer survival and confirms the results on 12,381 independent patients. Aggregating the prognostic effects of genetic variants across multiple genes, we identify four gene modules associated with survival in estrogen receptor (ER)-negative and one in ER-positive disease. The modules show biological enrichment for cancer-related processes such as G-alpha signaling, circadian clock, angiogenesis, and Rho-GTPases in apoptosis.
  •  
3.
  • Hill, Rebecca M., et al. (author)
  • Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
  • 2015
  • In: Cancer Cell. - : Elsevier BV. - 1535-6108 .- 1878-3686. ; 27:1, s. 72-84
  • Journal article (peer-reviewed)abstract
    • We undertook a comprehensive clinical and biological investigation of serial medulloblastoma biopsies obtained at diagnosis and relapse. Combined MYC family amplifications and P53 pathway defects commonly emerged at relapse, and all patients in this group died of rapidly progressive disease postrelapse. To study this interaction, we investigated a transgenic model of MYCN-driven medulloblastoma and found spontaneous development of Trp53 inactivating mutations. Abrogation of p53 function in this model produced aggressive tumors that mimicked characteristics of relapsed human tumors with combined P53-MYC dysfunction. Restoration of p53 activity and genetic and therapeutic suppression of MYCN all reduced tumor growth and prolonged survival. Our findings identify P53-MYC interactions at medulloblastoma relapse as biomarkers of clinically aggressive disease that may be targeted therapeutically.
  •  
4.
  •  
5.
  •  
6.
  • Howell, Viive M, et al. (author)
  • Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
  • 2006
  • In: Journal of Molecular Diagnostics. - : Elsevier BV. - 1525-1578 .- 1943-7811. ; 8:5, s. 559-66
  • Journal article (peer-reviewed)abstract
    • Familial hyperparathyroidism, a disease of the parathyroid glands, may occur in conjunction with pituitary and pancreatic tumors (multiple endocrine neoplasia type I), kidney and bone tumors (hyperparathyroidism jaw tumor syndrome), or alone (familial isolated hyperparathyroidism). This study describes the development and validation of rapid scanning for mutations in two tumor suppressor genes linked to familial hyperparathyroidism-MEN1 and HRPT2. Denaturing high-performance liquid chromatography mutation scanning for MEN1 was performed using a set of 10 amplicons covering the nine coding exons and flanking intronic regions and for HRPT2 using a set of three amplicons for exons 1, 2, and 7 and flanking intronic regions, in which 80% of the mutations identified to date are located. All 52 MEN1 mutations or polymorphisms, 46 known and six unknown, were successfully detected. Mutation detection in exon 9 was not confounded by the presence of the common polymorphism D418D. In addition, all 10 HRPT2 mutations were successfully detected, and a two-step approach was able to distinguish IVS2 common polymorphisms from exon 2 mutations. The development of rapid denaturing high performance liquid chromatography mutation scanning of MEN1 and HRPT2 facilitates a molecular diagnosis of the associated familial syndromes for both clinically affected and at-risk family members.
  •  
7.
  • Kozubaev, Sandjar, et al. (author)
  • Expanding Modes of Reflection in Design Futuring
  • 2020
  • In: Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems. - New York, NY, USA : Association for Computing Machinery. ; , s. 1-15
  • Conference paper (peer-reviewed)abstract
    • Design futuring approaches, such as speculative design, design fiction and others, seek to (re)envision futures and explore alternatives. As design futuring becomes established in HCI design research, there is an opportunity to expand and develop these approaches. To that end, by reflecting on our own research and examining related work, we contribute five modes of reflection. These modes concern formgiving, temporality, researcher positionality, real-world engagement, and knowledge production. We illustrate the value of each mode through careful analysis of selected design exemplars and provide questions to interrogate the practice of design futuring. Each reflective mode offers productive resources for design practitioners and researchers to articulate their work, generate new directions for their work, and analyze their own and others’ work.
  •  
8.
  •  
9.
  • Shu, Xiang, et al. (author)
  • Associations of obesity and circulating insulin and glucose with breast cancer risk : a Mendelian randomization analysis
  • 2019
  • In: International Journal of Epidemiology. - : OXFORD UNIV PRESS. - 0300-5771 .- 1464-3685. ; 48:3, s. 795-806
  • Journal article (peer-reviewed)abstract
    • Background: In addition to the established association between general obesity and breast cancer risk, central obesity and circulating fasting insulin and glucose have been linked to the development of this common malignancy. Findings from previous studies, however, have been inconsistent, and the nature of the associations is unclear. Methods: We conducted Mendelian randomization analyses to evaluate the association of breast cancer risk, using genetic instruments, with fasting insulin, fasting glucose, 2-h glucose, body mass index (BMI) and BMI-adjusted waist-hip-ratio (WHRadj BMI). We first confirmed the association of these instruments with type 2 diabetes risk in a large diabetes genome-wide association study consortium. We then investigated their associations with breast cancer risk using individual-level data obtained from 98 842 cases and 83 464 controls of European descent in the Breast Cancer Association Consortium. Results: All sets of instruments were associated with risk of type 2 diabetes. Associations with breast cancer risk were found for genetically predicted fasting insulin [odds ratio (OR) = 1.71 per standard deviation (SD) increase, 95% confidence interval (CI) = 1.26-2.31, p = 5.09 x 10(-4)], 2-h glucose (OR = 1.80 per SD increase, 95% CI = 1.3 0-2.49, p = 4.02 x 10(-4)), BMI (OR = 0.70 per 5-unit increase, 95% CI = 0.65-0.76, p = 5.05 x 10(-19)) and WHRadj BMI (OR = 0.85, 95% CI = 0.79-0.91, p = 9.22 x 10(-6)). Stratified analyses showed that genetically predicted fasting insulin was more closely related to risk of estrogen-receptor [ER]-positive cancer, whereas the associations with instruments of 2h glucose, BMI and WHRadj BMI were consistent regardless of age, menopausal status, estrogen receptor status and family history of breast cancer. Conclusions: We confirmed the previously reported inverse association of genetically predicted BMI with breast cancer risk, and showed a positive association of genetically predicted fasting insulin and 2-h glucose and an inverse association of WHRadj BMI with breast cancer risk. Our study suggests that genetically determined obesity and glucose/insulin-related traits have an important role in the aetiology of breast cancer.
  •  
10.
  • Sondergaard, Marie Louise Juul, et al. (author)
  • Fabulation as an Approach for Design Futuring
  • 2023
  • In: DESIGNING INTERACTIVE SYSTEMS CONFERENCE, DIS 2023. - : Association for Computing Machinery (ACM). ; , s. 1693-1709, s. 1693-1709
  • Conference paper (peer-reviewed)abstract
    • Envisioning alternative futures and desirable worlds is a core element of design that must be cultivated, especially when a deep transition of practices, values, and power is necessary for vibrant and just future lifeworlds. In this paper, we contribute towards fabulation as an approach for design futuring that foregrounds feminist commitments and more-than-human concerns. Analyzing two fabulation case studies around biodata and bodily fuids, we ofer three themes based on our process of developing these fabulations: how they engage materials, how they work to trouble temporalities, and how they cultivate imagination. We argue for the emerging potential of fabulation as an approach for open-ended, joyful design futuring, mobilizing speculative storytelling to foreground absent or neglected relations when imagining alternative lifeworlds.
  •  
11.
  • Tucker, Jason, et al. (author)
  • Fabulating Futures for Flourishing and Vibrant Worlds
  • 2023
  • In: The 10th Nordic Design Research Society (Nordes) Conference.
  • Conference paper (peer-reviewed)abstract
    • This one-day workshop will explore fabulations in design research. Bringing together design researchers and practitioners in hands-on exploration and critical dialogue, we will explore emerging practices and potentials of using fabulations in futures-oriented and exploratory practice-based design research. Drawing on fabulations’ relations with feminist technoscience and more-than-human concerns, we seek to understand if and how the practice of fabulating can contribute to designing vibrant worlds that can flourish in new ways.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-11 of 11
Type of publication
journal article (7)
conference paper (3)
other publication (1)
Type of content
peer-reviewed (8)
other academic/artistic (3)
Author/Editor
Olsson, Håkan (2)
Nevanlinna, Heli (2)
Blomqvist, Carl (2)
Chang-Claude, Jenny (2)
Kaaks, Rudolf (2)
Wang, Qin (2)
show more...
Wolk, Alicja (2)
Haiman, Christopher ... (2)
Gapstur, Susan M (2)
Giles, Graham G (2)
Brenner, Hermann (2)
John, Esther M (2)
Neuhausen, Susan L (2)
Gago Dominguez, Manu ... (2)
Arndt, Volker (2)
Canzian, Federico (2)
Milne, Roger L. (2)
Bolla, Manjeet K. (2)
Dennis, Joe (2)
Dunning, Alison M. (2)
Andrulis, Irene L. (2)
Anton-Culver, Hoda (2)
Auer, Paul L. (2)
Behrens, Sabine (2)
Benitez, Javier (2)
Bermisheva, Marina (2)
Bojesen, Stig E. (2)
Brauch, Hiltrud (2)
Burwinkel, Barbara (2)
Chenevix-Trench, Geo ... (2)
Clarke, Christine L. (2)
Cox, Angela (2)
Cross, Simon S. (2)
Czene, Kamila (2)
Daly, Mary B. (2)
Dwek, Miriam (2)
Eccles, Diana M. (2)
Evans, D. Gareth (2)
Fasching, Peter A. (2)
Figueroa, Jonine (2)
Gaudet, Mia M. (2)
Gonzalez-Neira, Anna (2)
Guenel, Pascal (2)
Hall, Per (2)
Hamann, Ute (2)
Hopper, John L. (2)
Howell, Anthony (2)
Jakubowska, Anna (2)
Kitahara, Cari M. (2)
Kristensen, Vessela ... (2)
show less...
University
Uppsala University (5)
Umeå University (2)
Royal Institute of Technology (2)
Lund University (2)
Karolinska Institutet (2)
University of Gothenburg (1)
show more...
Linköping University (1)
Malmö University (1)
show less...
Language
English (11)
Research subject (UKÄ/SCB)
Medical and Health Sciences (6)
Humanities (3)
Natural sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view